Fractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential

Essential Involvement of CX3CR1-Mediated Signals in the Bactericidal Host Defense during Septic Peritonitis

(2014) Y. Ishida et al.   JOURNAL OF IMMUNOLOGY

Pancreatic Neuropathy Results in “Neural Remodeling” and Altered Pancreatic Innervation in Chronic Pancreatitis and Pancreatic Cancer

(2009) Güralp Onur Ceyhan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Effect of pro-inflammatory cytokine stimulation on human breast cancer: Implications of chemokine receptor expression in cancer metastasis

(2009) Julio E. Valdivia-Silva et al.   CANCER LETTERS

Membrane Microvesicles as Actors in the Establishment of a Favorable Prostatic Tumoral Niche: A Role for Activated Fibroblasts and CX3CL1-CX3CR1 Axis

(2009) D. Castellana et al.   CANCER RESEARCH

An engineered CX3CR1 antagonist endowed with anti-inflammatory activity

(2009) Karim Dorgham et al.   JOURNAL OF LEUKOCYTE BIOLOGY

The Liberation of Fractalkine in the Dorsal Horn Requires Microglial Cathepsin S

(2009) A. K. Clark et al.   JOURNAL OF NEUROSCIENCE

Neural fractalkine expression is closely linked to pain and pancreatic neuritis in human chronic pancreatitis

(2009) Güralp O Ceyhan et al.   LABORATORY INVESTIGATION

Expression of Fractalkine (CX3CL1) and Its Receptor in Endotoxin-Induced Uveitis

(2009) Liqun Chu et al.   OPHTHALMIC RESEARCH

Pancreatic pain

(2008) Güralp O. Ceyhan et al.   BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY

The involvement of the fractalkine receptor in the transmigration of neuroblastoma cells through bone-marrow endothelial cells

(2008) Ido Nevo et al.   CANCER LETTERS

CX3CR1 Is Expressed by Prostate Epithelial Cells and Androgens Regulate the Levels of CX3CL1/Fractalkine in the Bone Marrow: Potential Role in Prostate Cancer Bone Tropism

(2008) W. L. Jamieson et al.   CANCER RESEARCH

The Chemokine Receptor CX3CR1 Is Involved in the Neural Tropism and Malignant Behavior of Pancreatic Ductal Adenocarcinoma

(2008) Federica Marchesi et al.   CANCER RESEARCH

Chemokine Markers Predict Biochemical Recurrence of Prostate Cancer following Prostatectomy

(2008) D. L. Blum et al.   CLINICAL CANCER RESEARCH

Pancreatic Neuropathy and Neuropathic Pain—A Comprehensive Pathomorphological Study of 546 Cases

(2008) Güralp O. Ceyhan et al.   GASTROENTEROLOGY

Intra-neural administration of fractalkine attenuates neuropathic pain-related behaviour

(2008) Fiona E. Holmes et al.   JOURNAL OF NEUROCHEMISTRY

Role of the fractalkine receptor CX3CR1 polymorphisms V249I and T280M as risk factors for early‐onset coronary artery disease in patients with no classic risk factors

(2008) B. A. Nassar et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans

(2008) Mikihiko Yasuda et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia

(2007) J. Ryu et al.   CARDIOVASCULAR RESEARCH

Fractalkine Deficiency Markedly Reduces Macrophage Accumulation and Atherosclerotic Lesion Formation in CCR2 −/− Mice

(2007) Noah Saederup et al.   CIRCULATION

The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection

(2007) Hermann E. Wasmuth et al.   JOURNAL OF HEPATOLOGY